Paper42827554PubMed
The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability.
Shi G and 6 others. Front Oncol, 2026.
Cite this record
ConductScience Library. The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability. Papers, record 42827554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42827554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The deubiquitinating enzyme UCHL3 promotes bladder cancer progression and glycolysis through enhancing PKM2 protein stability.
- Journal
- Front Oncol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37524875 | The deubiquitinase UCHL3 mediates p300-dependent chemokine signaling in alveolar type II cells to promote pulmonary fibrosis. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37524875 | PubMed |
| 2 | 31477831 | UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway. | Oncogene | 2020 | https://conductscience.org/library/papers/31477831 | PubMed |
| 3 | 39183237 | Structural basis for allosteric regulation of human phosphofructokinase-1. | Nat Commun | 2024 | https://conductscience.org/library/papers/39183237 | PubMed |
| 4 | 34903602 | PKM2 Is Essential for Bladder Cancer Growth and Maintenance. | Cancer Res | 2022 | https://conductscience.org/library/papers/34903602 | PubMed |
| 5 | 22056988 | Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. | Nature | 2011 | https://conductscience.org/library/papers/22056988 | PubMed |
| 6 | 36899022 | Phosphoglycerate dehydrogenase activates PKM2 to phosphorylate histone H3T11 and attenuate cellular senescence. | Nat Commun | 2023 | https://conductscience.org/library/papers/36899022 | PubMed |
| 7 | 34355179 | Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents. | RSC Med Chem | 2021 | https://conductscience.org/library/papers/34355179 | PubMed |
| 8 | 38720298 | ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38720298 | PubMed |
| 9 | 38762193 | Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38762193 | PubMed |
| 10 | 33201207 | Bladder Cancer: A Review. | JAMA | 2020 | https://conductscience.org/library/papers/33201207 | PubMed |
| 11 | 40451468 | UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma. | Free Radic Biol Med | 2025 | https://conductscience.org/library/papers/40451468 | PubMed |
| 12 | 35973989 | DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35973989 | PubMed |
| 13 | 39027256 | KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39027256 | PubMed |
| 14 | 40178292 | RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40178292 | PubMed |
| 15 | 34272515 | Cancer metabolism: looking forward. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34272515 | PubMed |
| 16 | 36371026 | Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/36371026 | PubMed |
| 17 | 40691601 | UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40691601 | PubMed |
| 18 | 33991457 | The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/33991457 | PubMed |
| 19 | 39419941 | USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma. | Cell Oncol (Dordr) | 2024 | https://conductscience.org/library/papers/39419941 | PubMed |
| 20 | 38385089 | USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma. | Int J Biol Sci | 2024 | https://conductscience.org/library/papers/38385089 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42827554
GET https://conductscience.org/api/papers/v1/42827554/references?page=2